Added to YB: 2024-04-12
Pitch date: 2024-04-10
SUS.ST [bullish]
Surgical Science Sweden AB (publ)
-78%
current return
Author Info
RhinoInsight shares data-driven investment research. Sign up for the newsletter.
Company Info
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally.
Market Cap
SEK 7.3B
Pitch Price
SEK 150.80
Price Target
244.60 (+637%)
Dividend
N/A
EV/EBITDA
32.68
P/E
35.24
EV/Sales
7.93
Sector
Health Care Equipment and Supplies
Category
growth
Surgical Science: Leading Supplier of Medical Simulators and Software for Robotic Surgery
SUS.ST: Leading medical simulation provider w/ 39% CAGR 2013-23. Strong growth from RAS partnerships (Intuitive, J&J). High-margin 90%+ GM licensing 2/3 of Industry/OEM rev (+24% YoY). No debt, 0.9x equity/asset, SEK630M cash for M&A. RAS market to hit $14B by '26, 11% CAGR. 22% FCF growth priced in seems achievable given RAS tailwinds & licensing upside. Risks: Customer concentration, big tech competition.
Read full article (10 min)